One of the most concerning adverse events during treatment with psychostimulants relates to their possible cardiovascular effects. ....In a study recently published in the BMJ, Shin J.Y. et al. (2016) set out to address this issue using a study design, namely self controlled case series analysis, that allowed for the control of possible confounding factors.